Gain Therapeutics, Inc. (GANX) vs Verrica Pharmaceuticals Inc. (VRCA)
A side-by-side comparison of Gain Therapeutics, Inc. and Verrica Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GANX
Gain Therapeutics, Inc.
$1.67HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT
VRCA
Verrica Pharmaceuticals Inc.
$4.28HealthcareDelayed quote: Oct 6, 2026, 3:37 PM EDT
Total return — GANX vs VRCA
growth of $100 · dividends reinvested · last 6yGANX -84.9% (-27.0%/yr)VRCA -97.4% (-45.5%/yr)GANX compounded faster over this window
Log scale — wide-divergence pair
GANX VRCA
GANX vs VRCA: by the numbers
- •VRCA is the larger company ($74M vs $71M market cap).
- •Both run net losses; GANX's is the smaller (0.00% vs -102.84% net margin).
Metrics side by side
Valuation
| Metric | GANX | VRCA |
|---|---|---|
| P/S ratio | N/A | 2.43 |
| P/B ratio | 6.31 | 17.08 |
Profitability
| Metric | GANX | VRCA |
|---|---|---|
| Gross margin | 0.00% | 85.89% |
| Operating margin | 0.00% | -33.56% |
| Net margin | 0.00% | -102.84% |
| ROE | -178.06% | -724.01% |
| ROIC | -159.24% | -207.23% |
Growth (annualized)
| Metric | GANX | VRCA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 20.37% |
| Total return CAGR (5Y) | -25.06% | -48.68% |
Frequently asked
- How have GANX and VRCA total returns compared?
- Over the past 5 years, GANX delivered -25.06% and VRCA delivered -48.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Gain Therapeutics ROEVerrica Pharmaceuticals ROEGain Therapeutics operating marginVerrica Pharmaceuticals operating marginGain Therapeutics revenue growthVerrica Pharmaceuticals revenue growthGain Therapeutics free cash flowVerrica Pharmaceuticals free cash flow
Gain Therapeutics & Verrica Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.